Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an RAF1 Fusion

Authors :: Siraj M. Ali
Kevin B. Kim
Jeffrey S. Ross
Thomas Semrad
Mohammed Kashani-Sabet
Alexa B. Schrock
Mark I. Singer
Source :: JCO Precision Oncology. :1-6
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.

Subjects :: 0301 basic medicine
03 medical and health sciences
Cancer Research
030104 developmental biology
0302 clinical medicine
Oncology
Metastatic melanoma
business.industry
030220 oncology & carcinogenesis
MEK inhibitor
Cancer research
Medicine
business

Tools